Serum activin A, inhibin A, and follistatin concentrations in preeclampsia or small for gestational age pregnancies

Obstetrics and Gynecology

Volumn 99, Issue 2, 2002, Pages 267-274

  Keelan, Jeffrey A ^a,e   Taylor, Rennae ^b   Schellenberg, Jean Claude ^c   Groome, Nigel P ^d   Mitchell, Murray D ^a   North, Robyn A ^b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c Clin et Policlin d'Ophtalmologie   (Switzerland)

^d OXFORD BROOKES UNIVERSITY   (United Kingdom)

^e THE UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN A; FOLLISTATIN; INHIBIN A;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREGNANCY; PREGNANCY DISORDER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEINURIA; SYSTOLIC BLOOD PRESSURE;

ACTIVINS; ADULT; BLOOD PRESSURE; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FETAL GROWTH RETARDATION; FOLLISTATIN; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; INHIBIN-BETA SUBUNITS; INHIBINS; LONGITUDINAL STUDIES; PRE-ECLAMPSIA; PREGNANCY;

EID: 0036155195     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(01)01674-X     Document Type: Article

References (29)

1. Human cytotrophoblast differentiation/invasion is abnormal in preeclampsia
2. Structural analysis of placental terminal villi from growth-restricted pregnancies with abnormal umbilical artery Doppler waveforms
3. Circulating factors as markers and mediators of endothelial cell dysfunction in preeclampsia
4. Preeclampsia: An excessive maternal inflammatory response to pregnancy
5. Follistatin and activin: A potential intrinsic regulatory system within diverse tissues
6. Betaglycan binds inhibin and can mediate functional antagonism of activin signalling
7. Activin A and inhibin A as possible endocrine markers for pre-eclampsia
8. Comparison of maternal serum total activin A and inhibin A in normal,preeclamptic, and nonproteinuric gestationally hypertensive pregnancies
9. Increased maternal serum activin A but not follistatin levels in pregnant women with hypertensive disorders
10. Serum inhibin A and activin A are elevated prior to the onset of preeclampsia
11. Second-trimester maternal serum inhibin A concentration as an early marker for preeclampsia
12. Comparison of maternal serum total activin A and inhibin A in normal, preeclamptic, and nonproteinuric gestationally hypertensive pregnancies
13. Activin is a local regulator of human cytotrophoblast cell differentiation
14. Induction of differentiation of the human promyelocytic cell line HL-60 by activin/EDF
15. Inhibin and activin modulate human monocyte chemotaxis and human lymphocyte interferon-gamma production
16. Induction of prostanoid, nitric oxide, and cytokine formation in rat bone marrow derived macrophages by activin A
17. Activin A exerts both pro- and anti-inflammatory effects on human term gestational tissues
18. The activin-binding protein follistatin regulates autocrine endothelial cell activity and induces angiogenesis
19. Transforming growth factor-beta: Role in mediating serum-induced endothelin production by vascular endothelial cells
20. Follistatin and its role as an activin-binding protein
21. Follistatin: A multifunctional regulatory protein
22. Evaluation of a definition of pre-eclampsia
23. Update of growth percentiles for infants born in an Australian population
24. Detection of dimeric inhibin throughout the human menstrual cycle by two-site enzyme immunoassay
25. Development and application of a two-site enzyme immunoassay for the determination of 'total' activin-A concentrations in serum and follicular fluid
26. Development, validation and application of an ultra-sensitive two-site enzyme immunoassay for human follistatin
27. Activin A and inhibin A as possible endocrine markers for pre-eclampsia
28. Serum immunoreactive activin A levels in normal subjects and patients with various diseases
29. Human activin-A is expressed in the atherosclerotic lesion and promotes the contractile phenotype of smooth muscle cells